ISG15 and cancer: Indeed, deregulated ISG15 expression has been found in response to diverse cancer chemotherapeutic agents, such as paclitaxel in the treatment of ovarian carcinomas and 5-fluorouracil in the therapy of oesophageal cancer [26,27].